Results for the youngest age strata (2–5 years) have already been published, and it was found that insulin detemir was associated with similar glycaemic control, but a greater reduction in fasting plasma glucose and a lower rate of hypoglycaemia when compared with NPH insulin in these patients after 52 weeks 19. This evidence concerns the gene INS and Hypoglycemia.